share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  10/09 20:31

牛牛AI助理已提取核心訊息

On October 4, 2024, 180 Life Sciences Corp. announced it had regained compliance with Nasdaq's minimum shareholder equity requirement, following a decision by the Nasdaq Hearing Panel on July 1, 2024. The company will be monitored for one year to ensure ongoing compliance. However, 180 Life Sciences remains non-compliant with Nasdaq's audit committee requirements, specifically the need for at least three independent directors. The company has until the earlier of its next annual shareholders' meeting or May 7, 2025, to meet this requirement, with a deadline of November 4, 2024, if the shareholders' meeting occurs before that date. Failure to comply may lead to delisting, but the company is actively seeking qualified independent directors to regain compliance. Additionally, on October 9, 2024, 180 Life Sciences issued a press release about...Show More
On October 4, 2024, 180 Life Sciences Corp. announced it had regained compliance with Nasdaq's minimum shareholder equity requirement, following a decision by the Nasdaq Hearing Panel on July 1, 2024. The company will be monitored for one year to ensure ongoing compliance. However, 180 Life Sciences remains non-compliant with Nasdaq's audit committee requirements, specifically the need for at least three independent directors. The company has until the earlier of its next annual shareholders' meeting or May 7, 2025, to meet this requirement, with a deadline of November 4, 2024, if the shareholders' meeting occurs before that date. Failure to comply may lead to delisting, but the company is actively seeking qualified independent directors to regain compliance. Additionally, on October 9, 2024, 180 Life Sciences issued a press release about its re-compliance with the Equity Rule and its strategic shift towards the iGaming sector, following the acquisition of a leading iGaming platform technology. The company aims to leverage this technology to enter the rapidly growing global iGaming market, which is projected to reach over $160 billion by 2026. The new platform is expected to launch in the first quarter of 2025 and will incorporate blockchain technology for enhanced security and flexibility in payment options, including cryptocurrencies.
2024年10月4日,180 life sciences公司宣佈已重新符合納斯達克的最低股東權益要求,緊隨納斯達克聽證會於2024年7月1日作出的決定後。公司將受到一年的監督,以確保持續遵守規定。然而,180 life sciences仍未符合納斯達克的審計委員會要求,具體來說就是至少需要三名獨立董事。公司必須在其下一次年度股東大會或2025年5月7日之前達到這一要求,如果股東大會在此日期之前舉行,則截止日期爲2024年11月4日。未能達到要求可能導致終止上市,但公司正積極尋找合格的獨立董事以重新符合要求。另外,2024年10月9日,180 life sciences發佈了一份新聞稿,介紹了其...展開全部
2024年10月4日,180 life sciences公司宣佈已重新符合納斯達克的最低股東權益要求,緊隨納斯達克聽證會於2024年7月1日作出的決定後。公司將受到一年的監督,以確保持續遵守規定。然而,180 life sciences仍未符合納斯達克的審計委員會要求,具體來說就是至少需要三名獨立董事。公司必須在其下一次年度股東大會或2025年5月7日之前達到這一要求,如果股東大會在此日期之前舉行,則截止日期爲2024年11月4日。未能達到要求可能導致終止上市,但公司正積極尋找合格的獨立董事以重新符合要求。另外,2024年10月9日,180 life sciences發佈了一份新聞稿,介紹了其重新符合股權規則及戰略轉向iGaming板塊的情況,這是在收購領先的iGaming平台科技之後。該公司旨在利用這項技術進入預計到2026年將達到1600億美元的全球iGaming市場,新平台預計將於2025年第一季度推出,將引入區塊鏈技術,以提高安全性並提供包括加密貨幣在內的支付選項。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。